|
Growth Failure in Children With CML Receiving Imatinib Is Due to Disruption of GH/IGF-1 Axis (Narayanan et al, Pediatr Blood Cancer)
|
Apr/2013 |
|
Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty (Giona et al)
|
Sep/2012 |
|
How I treat: childhood CML (Andolina et al, 2011)
|
Dec/2011 |
|
Imatinib Has Adverse Effect on Growth in Children With Chronic Myeloid Leukemia (Bansal 2011)
|
Nov/2011 |
|
Imatinib Is Effective in Children With Previously Untreated CML in Early Chronic Phase: Results of the French National Phase IV Trial (Millot 2011)
|
Oct/2011 |
|
CML in Children: Diagnostics and Management (Suttorp, Tauer, Millot 2011)
|
Oct/2011 |
|
Pediatric phase I trial and pharmacokinetic study of dasatinib (Aplenc, 2011)
|
Oct/2011 |
|
Distinct Impact of Imatinib on Growth at Prepubertal and Pubertal Ages of Children with CML (Shim, 2011)
|
May/2011 |
|
Controversies in treatment of CML in children and adolescents: TKI versus BMT? (Suttorp et al, 2011)
|
Feb/2011 |
|
Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia (Belgaumi et al, 2010)
|
Jan/2010 |
|
Differing Age Patterns in Chronic Myeloid Leukemia (CML) by Racial Ethnic Group (Levine at al, 2010)
|
Jan/2010 |
|
Treatment of Pediatric CML in 2010: Use of Tyrosine Kinase Inhibitors and Stem Cell Transplantation (Suttorp et al, 2010)
|
Jan/2010 |
|
Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia (Haruko Shima et al, 2010)
|
Jan/2010 |
|
Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia (Asim Belgaumi et al, 2009)
|
Jan/2009 |
|
Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program (Muramatsu et al, 2009)
|
Jan/2009 |
|
Impact of imatinib on the in vitro osteoclastogenic differentiation of monocytes in children and adolescents with chronic myeloid leukemia (Jaeger, 2009)
|
Jan/2009 |
|
Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I (Suttorp et al, 2009)
|
Jan/2009 |
|
Molecular response of pediatric chronic myeloid leukemia (CML) with imatinib mesylate therapy (Basak, 2008)
|
Jan/2008 |
|
Prognosis of pediatric patients transplanted for Ph+ chronic myeloid leukemia in the period from 1989 to 2006 in the Czech Republic (Krol, 2008)
|
Jan/2008 |
|
Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia (Millot, 2005)
|
Jan/2005 |
|
Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy? (Pulsipher, 2004)
|
Jan/2004 |
|
Early blastic transformation following complete cytogenetic response in a pediatric chronic myeloid leukemia patient treated with imatinib mesylate (Morimoto)
|
Jan/2004 |
|
Stem cell transplantation for chronic myeloid leukemia in children (Cwynarski 2003)
|
Jan/2003 |
|
Build it and they will come (or will they?) (Casper, 2003)
|
Jan/2003 |
|
Stem cell transplantation for chronic myeloid leukemia in children (Cwynarski, 2003)
|
Jan/2003 |
